GB Sciences' Product Development Approach relies on: 1) Creation of cGMP-certified raw cannabis materials in the GrowBLOX and 2) Isolation of active cannabinoid and terpenoid ingredients from the raw materials in Post-Processing Procedures. The key factors to transforming plants into true medicine involves consistency in dosing, quality and efficacy. In order to accomplish these goals, we first process the whole plant and measure the individual cannabinoid and terpenoid profiles within different cannabis strains. We test these natural combinations of active ingredients for effectiveness in human phase IV trials. Then we can isolate individual active ingredients from the cannabis plant and compound the ideal ratios based on the desired effect for specific treatments. This ensures that the appropriate combinations of active cannabis-based ingredients are consistently produced and can be properly dosed within an effective treatment plan.